Innoviva, Inc. (INVA) vs Phibro Animal Health Corporation (PAHC)
A side-by-side comparison of Innoviva, Inc. and Phibro Animal Health Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INVA
Innoviva, Inc.
$20.83HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PAHC
Phibro Animal Health Corporation
$36.61HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — INVA vs PAHC
growth of $100 · dividends reinvested · last 10yINVA +94.5% (+6.9%/yr)PAHC +72.4% (+5.6%/yr)INVA compounded faster over this window
INVA PAHC
INVA vs PAHC: by the numbers
- •INVA is the larger company ($1.54B vs $1.48B market cap).
- •INVA trades at the lower trailing earnings multiple (5.08 vs 15.00 P/E), one valuation lens rather than an overall verdict.
- •INVA converts more revenue to profit (80.56% vs 6.57% net margin).
- •PAHC grew revenue faster over the past five years (12.75% vs 3.94% CAGR).
- •PAHC pays a dividend (1.29% yield), while INVA is a former payer with no current dividend run rate.
Metrics side by side
Valuation
| Metric | INVA | PAHC |
|---|---|---|
| P/E ratio | 5.08 | 15.00 |
| Forward P/E | 8.61 | 10.46 |
| PEG ratio | 0.49 | 1.18 |
| P/S ratio | 3.47 | 0.98 |
| P/B ratio | 1.25 | 3.85 |
| EV / EBITDA | 4.90 | 8.85 |
| FCF yield | 12.25% | 0.66% |
Profitability
| Metric | INVA | PAHC |
|---|---|---|
| Gross margin | 73.09% | 33.71% |
| Operating margin | 36.66% | 13.07% |
| Net margin | 80.56% | 6.57% |
| ROE | 28.97% | 25.87% |
| ROIC | 8.36% | 11.91% |
Dividends
| Metric | INVA | PAHC |
|---|---|---|
| Dividend yield | N/A | 1.29% |
| Payout ratio | N/A | 19.67% |
Growth (annualized)
| Metric | INVA | PAHC |
|---|---|---|
| Revenue CAGR (5Y) | 3.94% | 12.75% |
| EPS CAGR (5Y) | 12.71% | 12.92% |
| FCF CAGR (5Y) | -10.54% | -12.27% |
| Total return CAGR (5Y) | 4.52% | 14.40% |
Frequently asked
- Which has the lower trailing P/E, INVA or PAHC?
- INVA has the lower trailing P/E: INVA trades at 5.08 and PAHC at 15.00. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, INVA or PAHC?
- Over the past five years, PAHC grew revenue faster — INVA at a 3.94% CAGR versus PAHC at 12.75%.
- Does INVA or PAHC pay a bigger dividend?
- PAHC pays a dividend (1.29% yield), while INVA is a former payer with no current dividend run rate.
- Is INVA or PAHC more profitable?
- INVA runs the higher net margin — INVA at 80.56% versus PAHC at 6.57%.
- How have INVA and PAHC total returns compared?
- Over the past 10 years, INVA delivered 6.43% and PAHC delivered 5.27% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Innoviva P/E ratioPhibro Animal Health P/E ratioPhibro Animal Health dividend yieldInnoviva ROEPhibro Animal Health ROEInnoviva operating marginPhibro Animal Health operating marginInnoviva revenue growthPhibro Animal Health revenue growthInnoviva free cash flowPhibro Animal Health free cash flow
Innoviva & Phibro Animal Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.